Literature DB >> 19864499

Inhibition of the phosphatidylinositol 3-kinase-Akt pathway enhances gamma-2 herpesvirus lytic replication and facilitates reactivation from latency.

Li Peng1, Ting-Ting Wu, Jason H Tchieu, Jun Feng, Helen J Brown, Jiaying Feng, Xudong Li, Jing Qi, Hongyu Deng, Igor Vivanco, Ingo K Mellinghoff, Christina Jamieson, Ren Sun.   

Abstract

Cellular signalling pathways are critical in regulating the balance between latency and lytic replication of herpesviruses. Here, we investigated the effect of the phosphatidylinositol 3-kinase (PI3K)-Akt pathway on replication of two gamma-2 herpesviruses, murine gammaherpesvirus-68 (MHV-68) and human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus (HHV-8/KSHV). We found that de novo infection of MHV-68 induced PI3K-dependent Akt activation and the lytic replication of MHV-68 was enhanced by inhibiting the PI3K-Akt pathway with both chemical inhibitors and RNA interference technology. Inhibiting the activity of Akt using Akt inhibitor VIII also facilitated the reactivation of KSHV from latency. Both lytic replication and latency depend on the activity of viral transactivator RTA and we further show that the activity of RTA is increased by reducing Akt1 expression. The data suggest that the PI3K-Akt pathway suppresses the activity of RTA and thereby contributes to the maintenance of viral latency and promotes tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19864499      PMCID: PMC2888311          DOI: 10.1099/vir.0.015073-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  39 in total

1.  Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.

Authors:  R Swart; I K Ruf; J Sample; R Longnecker
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus.

Authors:  M J Song; H J Brown; T T Wu; R Sun
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Prostratin and bortezomib are novel inducers of latent Kaposi's sarcoma-associated herpesvirus.

Authors:  Helen J Brown; William H McBride; Jerome A Zack; Ren Sun
Journal:  Antivir Ther       Date:  2005

4.  Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors.

Authors:  Craig W Lindsley; Zhijian Zhao; William H Leister; Ronald G Robinson; Stanley F Barnett; Deborah Defeo-Jones; Raymond E Jones; George D Hartman; Joel R Huff; Hans E Huber; Mark E Duggan
Journal:  Bioorg Med Chem Lett       Date:  2005-02-01       Impact factor: 2.823

5.  Quantitative analysis of anti-apoptotic function of Akt in Akt1 and Akt2 double knock-out mouse embryonic fibroblast cells under normal and stressed conditions.

Authors:  Xuesong Liu; Yan Shi; Morris J Birnbaum; Keqiang Ye; Ron De Jong; Tillman Oltersdorf; Vincent L Giranda; Yan Luo
Journal:  J Biol Chem       Date:  2006-08-21       Impact factor: 5.157

6.  The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B.

Authors:  S Montaner; A Sodhi; S Pece; E A Mesri; J S Gutkind
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

7.  Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression.

Authors:  Sathish Sadagopan; Neelam Sharma-Walia; Mohanan Valiya Veettil; Hari Raghu; Ramu Sivakumar; Virginie Bottero; Bala Chandran
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

8.  Persistent gammaherpesvirus replication and dynamic interaction with the host in vivo.

Authors:  Seungmin Hwang; Ting-Ting Wu; Leming M Tong; Kyeong Seon Kim; DeeAnn Martinez-Guzman; Arnaud D Colantonio; Christel H Uittenbogaart; Ren Sun
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

9.  Herpes simplex virus type 2 entry into cultured human corneal fibroblasts is mediated by herpesvirus entry mediator.

Authors:  Vaibhav Tiwari; Shripaad Y Shukla; Beatrice Y J T Yue; Deepak Shukla
Journal:  J Gen Virol       Date:  2007-08       Impact factor: 3.891

10.  Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus.

Authors:  Fuqu Yu; Josephine N Harada; Helen J Brown; Hongyu Deng; Moon Jung Song; Ting-Ting Wu; Juran Kato-Stankiewicz; Christian G Nelson; Jeffrey Vieira; Fuyuhiko Tamanoi; Sumit K Chanda; Ren Sun
Journal:  PLoS Pathog       Date:  2007-03       Impact factor: 6.823

View more
  28 in total

1.  Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection.

Authors:  Benson Yee Hin Cheng; Jizu Zhi; Alexis Santana; Sohail Khan; Eduardo Salinas; J Craig Forrest; Yueting Zheng; Shirin Jaggi; Janet Leatherwood; Laurie T Krug
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

2.  FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.

Authors:  Ruoyun Gao; Tingting Li; Brandon Tan; Suzane Ramos da Silva; Jae U Jung; Pinghui Feng; Shou-Jiang Gao
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

3.  Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.

Authors:  Sathish Sadagopan; Mohanan Valiya Veettil; Nitika Paudel; Virginie Bottero; Bala Chandran
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

4.  Protein kinase inhibitors that inhibit induction of lytic program and replication of Epstein-Barr virus.

Authors:  R Goswami; S Gershburg; A Satorius; E Gershburg
Journal:  Antiviral Res       Date:  2012-10-08       Impact factor: 5.970

Review 5.  The role of PI3K/Akt in human herpesvirus infection: From the bench to the bedside.

Authors:  XueQiao Liu; Jeffrey I Cohen
Journal:  Virology       Date:  2015-03-20       Impact factor: 3.616

6.  Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Xudong Li; Shijia Chen; Ren Sun
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

7.  Gene expression and transcription factor profiling reveal inhibition of transcription factor cAMP-response element-binding protein by gamma-herpesvirus replication and transcription activator.

Authors:  Helen J Brown; Li Peng; Josephine N Harada; John R Walker; Steven Cole; Su-Fang Lin; Jerome A Zack; Sumit K Chanda; Ren Sun
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

8.  Nature and duration of growth factor signaling through receptor tyrosine kinases regulates HSV-1 latency in neurons.

Authors:  Vladimir Camarena; Mariko Kobayashi; Ju Youn Kim; Pamela Roehm; Rosalia Perez; James Gardner; Angus C Wilson; Ian Mohr; Moses V Chao
Journal:  Cell Host Microbe       Date:  2010-10-21       Impact factor: 21.023

Review 9.  A cultured affair: HSV latency and reactivation in neurons.

Authors:  Angus C Wilson; Ian Mohr
Journal:  Trends Microbiol       Date:  2012-09-07       Impact factor: 17.079

10.  Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency.

Authors:  Michael A Rak; Jason Buehler; Sebastian Zeltzer; Justin Reitsma; Belen Molina; Scott Terhune; Felicia Goodrum
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.